← Back to Domains
Health

NHS & Health

Waiting List
6.24 million
Productivity
-17% since 2018
Outcomes Rank
Last of 10 peers
38%Current
Potential: 72%

βœ—Key Problems

  • 1.6.24M waiting list - still 2.5x pre-COVID levels
  • 2.Productivity DOWN 17% since 2018 - more staff, worse outcomes
  • 3.Last of 10 peer countries on cancer survival, strokes
  • 4.Β£185bn/yr spent - double 2010 - for WORSE results

βœ“Solutions

  • 1.PATIENT CHOICE VOUCHER: 13-week wait = Β£500 for private treatment (Sweden model)
  • 2.ANY QUALIFIED PROVIDER: Patient choice drives quality (Netherlands model)
  • 3.STREAMLINE NHS ENGLAND: Reduce Β£2bn admin overhead (McKinsey review)
  • 4.PERFORMANCE ACCOUNTABILITY: Transparent metrics, managed exit for underperformers
πŸ”¬

Analysis

Root Causes

1

6.24M waiting list - still 2.5x pre-COVID levels

2

Productivity DOWN 17% since 2018 - more staff, worse outcomes

3

Last of 10 peer countries on cancer survival, strokes

4

Β£185bn/yr spent - double 2010 - for WORSE results

Reform Pathway

1

PATIENT CHOICE VOUCHER: 13-week wait = Β£500 for private treatment (Sweden model)

2

ANY QUALIFIED PROVIDER: Patient choice drives quality (Netherlands model)

3

STREAMLINE NHS ENGLAND: Reduce Β£2bn admin overhead (McKinsey review)

4

PERFORMANCE ACCOUNTABILITY: Transparent metrics, managed exit for underperformers

Policy Costings

Rigorous fiscal analysis of NHS & Health reforms

View All Costings β†’
πŸ₯Health

Nhs Productivity

Upfront
+Β£3.0bn
Annual
-Β£12.0bn
Revenue
+Β£4.0bn
Net Annual Effect
-Β£8.0bn/year
Payback in 2 years
GDP +0.8%Productivity +0.2%high uncertainty
3 sources
The NHS Under Pressure - Infographic
The NHS Under Pressure β€’ Data sources cited in image